Though severe forms of rheumatoid arthritis are associated with constitutional illness, the majority of patients suffer mainly from pain and disability in a limited number of joints. To treat this relatively confined zone of aggravation, the patient must usually take an oral anti-inflammatory agent which affects the whole body often with the most profound unwanted effects. Clearly, it would be a great advantage ifappropriate treatment could be aimed only at the affected joint or joints. In the case of the extremity it is relatively easy to confine an injected drug to the affected part by the application of an arterial tourniquet. The intravenous injection of local anaesthetic into the isolated limb is a well established method of providing regional anaesthesia for surgery on the extremity, which began with Bier's use of procaine in this way in 1908 1 . In the past 15 years guanethidine has been targeted on to the sympathetic nerve endings in isolated limbs in a kind of Bier's block to alleviate a variety of painful disabilities in limbs-, The considerable success of such guanethidine blocks in the treatment of reflex sympathetic dystrophies is not only clinically rewarding but has engendered many new ideas about the aetiology of these enigmatic conditions including their relationship to rheumatoid arthritis.
The objectives of this discussion paper are to outline the principles and practice of pharmacological target blocks and the use of non-drug methods to produce sympathetic modulation in the relief of painful disorders in limbs, especially in relation to the new light they throw upon the aetiology of the articular and extra-articular features of rheumatoid arthritis. Much of the information given in this article reflects the author's views but the enigmatic nature of the set of disease processes known as rheumatoid arthritis strongly invites speculation.
Clinical methods of drug targeting
Successful drug targeting requires the availability of a suitable drug and a discrete target. The method of delivery will require consideration of the portal of entry for the drug, guidance of the drug along the path to the target and the confinement of the drug to the target. Clinically, there are three basic methods of drug targeting: transdermal inunction, percutaneous injection and intravenous regional perfusion. Peripheral arterial perfusion is not a technique for general clinical use owing to the difficulties and hazards posed by arterial cannulation.
Transdermal inunction
The topical application of medications can be effective when certain drugs are used on mucous membranes but this method is generally doomed to failure by the effectiveness of the skin barrier. Hence, transdermal inunction has largely fallen into disrepute but we should not be defeatist as new developments are possible. Lately there has been a resurgence of interest in the technology of transdermal drug therapy. In relation to dermal anaesthesia, a happy accident in the Astra laboratories occurred when lignocaine and prilocaine crystals became mixed together in equal proportions. The resulting eutectic mixture was liquid at room temperature and could be emulsified into a cream of high anaesthetic potency and, for the first time, a truly potent transdermallocal anaesthetic preparation became available on the market (EMLA cream, Astra). The development of a dermis-penetrating anti-inflammatory drug preparation might be of considerable use in the alleviation of early extra-articular and peri-articular rheumatoid disease. It is uncertain whether passive inunction can be 'power assisted' successfully with iontophoresis or phonophoresis" to increase the depth of penetration of the agent and enable it to reach the small joints in the extremities.
Percutaneous injection
Simple injection techniques with local anaesthetic and steroid preparations into tender trigger points are relatively common practice and can be most useful if used cautiously. With a little more expertise it is possible to direct injected solutions along fascial planes and sheaths to wider areas and towards more distant targets. The use of image intensified biplanar X-ray control, computerised axial tomography and the gamma camera can be used to identify targets and to track the delivery of suitably marked drug solutions to their targets.
An expert knowledge of regional local anaesthetic blocks can be most useful in the acute stage of complications associated with rheumatoid disease. For example, in the hand-shoulder syndrome, the pain, stiffness and swelling in the hand and to a lesser extent in the shoulder may respond well to stellate ganglion block with local anaesthetic solution. The improvement can be immediate and the blocks can be repeated to maintain the improvement. If it is more a case of shoulder-hand syndrome or simply the frozen-shoulder syndrome, the pain and stiffness in the shoulder may be alleviated by an interscalene local anaesthetic block. The importance of the rapid and profound relief of pain is that physiotherapy can be effectively applied to restore function in the affected part. Breaking the vicious circle of pain and muscle spasm can give relief which long outlasts 0141-0768/90/ 060373-04·$02.00/0 © 1990 The Royal Society of Medicine Table 1 . Properties of the ideal target-blocking drug 1 Suitable parenteral preparation available 2 Licence available for proposed use 3 No initial stimulation of target 4 Selective take-up by target 5 High affinity for target 6 Fast take-up by target 7 Slow leaching off target 8 Accumulation in target 9 Progressive effect on target with repetition 10 Prolonged effect on target the~ffect of the block and the respite is naturally a considerahls, boost to the patient's morale.
Intravenous regional perfusion blocks Guanethidine block
Guanethidine was the drug that established a place for the intravenous regional deposition of drugs in the extremities to relieve persistent pain and disability. The prime purpose was to block the sympathetic nerve supply to the upper or lower extremity by attacking he nerve terminals rather than the ganglion chain In the neck or lumbar region, respectively. The resulting sympathetic block is not only more profound than the ganglion block but is a more specific kind of block. The guanethidine block is purely antinoradrenergic whereas the ganglion block is both anti-noradrenergic and anti-cholinergic. This is one of the reasons that the intravenous regional guanethidine block has been so important to our understanding of the mechanisms of causalgia and sympathetic dystrophies in general", The attributes of the ideal target-blocker are summarized in Table  1 and most of these are possessed by guanethidine. Guanethidine initially releases noradrenaline from the sympathetic nerve endings before blocking them and can therefore exacerbate the pain of sympathetic dystrophy in the early minutes of the block. This effect can be kept to a minimum by reducing the dose of the drug during the first block, a necessity in patients with a history of Raynaud's phenomenon. A complete account of the guanethidine technique is given elsewhere-, and only fully informed doctors who are accustomed to using and applying tourniquets should attempt the technique. Guanethidine blocks can be useful as an interventional kind of treatment in rheumatoid arthritis. The following case report is illustrative.
Case report
A woman aged 47 presented in the pain clinic with an exacerbation of the painful rheumatoid arthritis in her hands. She had had a variety of non-steroidal antiinflammatory agents and the onset of cold, damp weather was threatening to defeat the control of the symptoms by the current drug. She was relunctant to increase the dose of the drug in case this precipitated her indigestion as e~perienced in the past. She felt that anything that would tide her over the seasonal change in the weather would be sufficient. She was given a guanethidine block of the dominant, most affected hand and much of the pain and ti ffne88 disappeared from the treated hand in minutes. The Improvement lasted 8 days, during which she was able to move her fingers, wrist and elbow on the treated side without di~comfo~.~oreover, she noted that a persistent painful trigger pomt In the muscle above the elbow had disappeared. During this period the weather had grown colder and the pain and disability in the untreated hand were worse as she had learned to expect. She considered that the guanethidine had had a protective effect on the treated limb and she requested that guanethidine blocks should be given her on the change of seasons. In the next 12 months she needed block treatment at the onset of winter, late spring and late summer -most likely associated with wet, chilly weather prevailing at these times. The following 12 months were less inclement and no blocks were required. One block was required at the onset of autumn in the next year.
Lysine acetylsalicyclic acid block
This preparation is not generally available in the United Kingdom so that discussion of this kind of block is included only because of its important theoretical implications. Lysine acetylsalicylic acid is essentially a very soluble preparation of aspirin suitable for intravenous injection. I have used this preparation in an intravenous regional technique particularly to relieve the deep ache that can remain despite guanethidine treatment in reflex sympathetic dystrophy and rheumatoid arthritis. Guanethidine is most effective in relieving the superficial burning kind of pain, more in the nature of causalgia. The finding that patients with rheumatoid arthritis can be relieved especially of the burning component of their pain suggests that this aspect of their pain has a noradrenergic trigger. Pain with a noradrenergic trigger would be expected to vary with activity in the peripheral sympathetic nervous system and this association might explain why rheumatoid patients suffer in relation to climatic changes.
The response of the deep aching pain to lysine acetylsalicylic acid in an intravenous regional block suggests that this type of pain has a prostaglandin or bradykinin trigger. The finding that superficial burning pain and deep aching pain have quite different triggering mechanisms supports the long held clinical impression that these two types of pain have fundamentally different characteristics and diagnostic associations. Finally, it is interesting that relief of the burning pain by guanethidine can unmask deep aching pain of which the patient was not previously aware.
Associated neuropathy
A noteworthy extra cause of pain in rheumatoid limbs is the complication of compression neuropathy. The common sites for this to occur in the upper limb are the wrist (median and ulnar nerves) and the elbow (ulnar nerve). The discomfort of nerve compression may at worst progress to causalgia especially as a complication of surgical release. The onset of causalgia is a definite indication for sympathetic block which is usually the only successful treatment for this distressing type of pain'', The peripheral nerve damage in a rheumatoid limb may occasionally be the result of fibrotic infiltration, ischaemia caused by vasculitis and possibly a toxic effect of the disease or its treatment. Pain in these instances may also respond to sympathetic block.
It may be countered that guanethidine and sympathetic ganglion blocks only work when there is a degree of peripheral neuropathy associated with rheumatoid arthritis. This is not the case and the pain which is relieved by various sympathetic blocking methods is no less than the rheumatoid inflammatory pain transduced by nerve endings in the tissues as with any other pain", 
Role of the sympathetic nervous system in rheumatoid arthritis
The clinical usefulness of guanethidine blocks on an interventional basis in the management of rheumatoid arthritis suggests that we should be looking more deeply into a possible contributory role of the sympathetic nervous system to the symptom-profile of this disease. An important question is whether it is possible that the sympathetic nervous system plays a part in triggering the disease itself. I have been struck by the similarities between the early stages of both reflex sympathetic dystrophy (RSD) and rheumatoid arthritis with regard to the nature of pain and disabilities in the extremity. The bilateral symmetry of the joints involved in rheumatoid arthritis could well be explained by the underlying symmetrical anatomy of the sympathetic nervous system. Patients with RSD of one hand may first realize that the opposite hand is affected to some degree when sympathetic block of the dystrophic limb is accompanied by an improvement in the mobility of the fingers in the opposite untreated hand. Bone scans of opposite extremities in RSD commonly show a degree of mirror image change in blood flow and bone activity on the clinically unaffected side.
The symmetry and characteristic radiation of sympathetically related events in the limbs may be better appreciated if we picture the sympathetic nervous system as organized into four quadrants (Figure 1) . It is likely that the spread of RSD from hand to shoulder, for instance, is the result of the spread of sympathetic activity within the quadrant controlled by the corresponding stellate ganglion. Local anaesthetic block of this stellate ganglion may not only relieve the symptoms and signs in the hand but free the shoulder from associated stiffness. Occasionally, patients with hand-shoulder syndrome complain of altered sensation in the cheek on the affected side. This also returns to normal after stellate ganglion block. Moreover, the common tender trigger point in the fold of the trapezius muscle above the affected shoulder may also disappear. I find that sympathetic block in a rheumatoid limb by either stellate ganglion block or guanethidine block may not Animal studies Guanethidine can produce widespread immunosympathectomy in neonatal ratst which are then protected from developing adjuvant arthritis", About 3 weeks after division of a peripheral limb nerve, rats begin to chew their claws and may even bite off their toes presumably because they have developed a kind of anaesthesia dolorosa in the affected part. This gnawing activity can be prevented by early treatment with large doses of guanethidine". If we assume that the destructive gnawing activity of the rats is indicative of their discomfort after developing the equivalent of sympathetic dystrophy, which is prevented by guanethidine, there is little doubt that the sympathetic nervous system must playa similar central role in the genesis of post nerve-injury dystrophy as well as in adjuvant arthritis.
The burning question is whether we should now be looking at a new line of preventive treatment in rheumatoid arthritis aimed at suppressing the regional sympathetic nervous system. It is possible that the sympathetic nerves can affect the actual initiation of the rheumatoid process because it is known that immunocompetent cells are replete with adrenoceptors of high affinity and specificity and that lymphoid tissue has a copious supply of sympathetic nerve fibres", The early recognition of individuals and families at risk from rheumatoid arthritis will be essential but it will be a formidable task because we know so little about the risk factors. The early stages of RSD and palindromic rheumatism can be confused'' and I believe that closer study of both these enigmatic conditions may reveal vital clues as to why some individuals react with regional aggressiveness to their own tissues. Do the sympathetic nerve endings supply the mediators which augment this regional mayhem?
Non-drug modulation of the sympathetic nervous system Whilst it is possible to alleviate exacerbations of rheumatoid arthritis in a particular limb in certain circumstances by blocking the regional sympathetic nerves, how may we generally dampen activity in the whole sympathetic nervous system in the hope of gaining an improvement without recourse to potent drugs? Rheumatoid arthritis can be made worse, and perhaps even precipitated, by stress so that a change to a more tranquil life style may be helpful. A patient's acquired ability to suppress her sympathogalvanic response (or galvanic skin response), a simple measure of sympathetic activity, is shown in Figure 2 .
This patient, a woman aged 53 years, developed causalgia in the territory of the ulnar nerve which had been transposed at the elbow where it had been involved in rheumatoid disease. The causalgia was unrelieved by analgesics and caused her great distress until the condition was brought under control with a series of guanethidine blocks. As she was shortly to emigrate to a country where parenteral guanethidine was unavailable, other treatment strategies had to be tried. She proved a good subject for hypnosis and she was taught to reduce the sympathetic tone in the affected limb and so reduce her pain. The sympathogalvanic response was used as a measure of this ability. In Figure 2 it may be seen that her very active sympathogalvanic response (trace A) was completely abolished during hypnosis when complete hypnoanalgesia was achieved (trace B) with total relief of pain. Subsequently, she was able to reduce the sympathetic tone by her own efforts as shown by the diminished sympathogalvanic response (trace C) recorded 3 months later. She was now able to produce autoanalgesia at will during exacerbations of the pain and life became tolerable for her.
Other useful forms of non-drug therapy in rheumatoid arthritis are acupuncture, transcutaneous electrical nerve stimulation (TENS), autorelaxation with biofeedback enhancement and various kinds of physical therapy. The use of non-drug interventional strategies might be an effective way of cutting the drug bill in rheumatoid arthritis but any savings would of course be at the cost ofexpensive professional time and facilities. The overall incidence of serious unwanted drug effects in rheumatoid patients is nevertheless high enough to warrant more recourse to non-drug therapy.
